Neonc Technologies Inc.
Calabasas, CA
- UEI
- TP8KS5F1YMM3
- CAGE
- 6C243
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 23975 Park Sorrento #205, Calabasas, CA 91302, USA
- Website
- neonc.com
- Founded
- 2008
- Industry
-
- Information Technology
- Software & Services
- Internet Software & Services
- SIC code
- 48 Communications
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas | National Cancer Institute | $336,000 | |
| Innovative nose-to-brain anticancer drug transport facilitated by NEO100 | National Cancer Institute | $301,450 | |
| Temozolomide perillyl alcohol conjugate as treatment for recurrent malignant brain tumors | National Institutes of Health | $300,000 |
Quick answers
What is Neonc Technologies Inc.'s UEI?
Neonc Technologies Inc.'s Unique Entity ID (UEI) in SAM.gov is TP8KS5F1YMM3.
What is Neonc Technologies Inc.'s CAGE code?
Neonc Technologies Inc.'s CAGE code is 6C243.
Where is Neonc Technologies Inc. located?
Neonc Technologies Inc.'s physical address in SAM.gov is 23975 Park Sorrento #205, Calabasas, CA 91302, USA.
Is Neonc Technologies Inc. registered in SAM.gov?
Yes. Neonc Technologies Inc.'s SAM.gov registration is active through December 23, 2026.
What is Neonc Technologies Inc.'s most recent federal award?
Neonc Technologies Inc.'s most recent federal grant award is Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas (R41CA246902), from National Cancer Institute, on April 1, 2020.
On GovTribe
See Neonc Technologies Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors